30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Myovant Sciences Ltd (MYOV)

Track

Stock chart
Ticker: MYOV Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sumitomo Chemical Co., Ltd.
1 purchase — total 1,393,178,400 USD
Buy 10 Mar 2023
Value US$1,269,023.69 | Price 17.25 | Shares 47,866
Sale 18 Jan 2023
Value US$3,234,658.49 | Price 418.47 | Shares 7,275
Sale 18 Jan 2023
Value US$53,995.12 | Price 26.89 | Shares 2,008
Sale 18 Jan 2023
Value US$34,204.08 | Price 26.89 | Shares 1,272
Sale 18 Jan 2023
Value US$216,114.93 | Price 26.89 | Shares 8,037
Sale 4 Jan 2023
Value US$60,551.90 | Price 26.90 | Shares 2,251
Sale 4 Jan 2023
Value US$74,755.10 | Price 26.90 | Shares 2,779
Sale 16 Dec 2022
Value US$59,946.75 | Price 26.75 | Shares 2,241
Sale 18 Oct 2022
Value US$281,131.20 | Price 25.20 | Shares 11,156
Sale 18 Oct 2022
Value US$40,420.80 | Price 25.20 | Shares 1,604
Sale 18 Oct 2022
Value US$42,915.60 | Price 25.20 | Shares 1,703
Sale 18 Oct 2022
Value US$48,711.60 | Price 25.20 | Shares 1,933
Sale 4 Oct 2022
Value US$89,767.60 | Price 24.40 | Shares 3,679
Sale 4 Oct 2022
Value US$66,807.20 | Price 24.40 | Shares 2,738
Sale 16 Sep 2022
Value US$174,322.98 | Price 18.86 | Shares 9,243
Sale 15 Aug 2022
Value US$569,031.22 | Price 18.23 | Shares 31,214
Sale 18 Jul 2022
Value US$20,669.22 | Price 12.87 | Shares 1,606
Sale 18 Jul 2022
Value US$24,903.45 | Price 12.87 | Shares 1,935
Sale 18 Jul 2022
Value US$21,930.48 | Price 12.87 | Shares 1,704
Sale 18 Jul 2022
Value US$143,680.68 | Price 12.87 | Shares 11,164
Sale 6 Jul 2022
Value US$36,917.00 | Price 13.40 | Shares 2,755
Sale 6 Jul 2022
Value US$49,606.80 | Price 13.40 | Shares 3,702
Sale 27 May 2022
Value US$13,916.74 | Price 10.07 | Shares 1,382
Sale 19 Apr 2022
Value US$48,404.40 | Price 10.45 | Shares 4,632
Sale 19 Apr 2022
Value US$73,662.05 | Price 10.45 | Shares 7,049
Sale 19 Apr 2022
Value US$257,007.30 | Price 10.45 | Shares 24,594
Sale 19 Apr 2022
Value US$83,620.90 | Price 10.45 | Shares 8,002
Sale 5 Apr 2022
Value US$26,485.16 | Price 13.78 | Shares 1,922
Sale 5 Apr 2022
Value US$33,568.08 | Price 13.78 | Shares 2,436
Sale 1 Mar 2022
Value US$18,182.70 | Price 13.35 | Shares 1,362
Sale 19 Jan 2022
Value US$291,867.76 | Price 14.68 | Shares 19,882
Sale 4 Jan 2022
Value US$36,949.17 | Price 16.27 | Shares 2,271
Sale 4 Jan 2022
Value US$72,808.25 | Price 16.27 | Shares 4,475
Sale 29 Nov 2021
Value US$38,175.40 | Price 19.30 | Shares 1,978
Planned sale 4 Nov 2021
Value US$74,462.00 | Price 24.02 | Shares 3,100
Planned sale 3 Nov 2021
Value US$16,800.00 | Price 24.00 | Shares 700
Sale 5 Oct 2021
Value US$59,195.56 | Price 21.62 | Shares 2,738
Sale 5 Oct 2021
Value US$144,227.02 | Price 21.62 | Shares 6,671
Planned sale 27 Sep 2021
Value US$170,240.00 | Price 24.32 | Shares 7,000
Planned buy 27 Sep 2021
Value US$55,486.18 | Price 24.86 | Shares 2,232
Planned buy 27 Sep 2021
Value US$1,106,903.66 | Price 24.19 | Shares 45,768
Planned buy 24 Sep 2021
Value US$842,547.60 | Price 23.40 | Shares 36,000
Planned buy 13 Sep 2021
Value US$717,990.50 | Price 23.91 | Shares 30,028
Planned buy 13 Sep 2021
Value US$1,227,058.10 | Price 23.09 | Shares 53,150
Planned buy 10 Sep 2021
Value US$753,390.00 | Price 25.11 | Shares 30,000
Planned sale 9 Sep 2021
Value US$124,063.00 | Price 25.58 | Shares 4,850
Planned buy 31 Aug 2021
Value US$946,884.90 | Price 24.28 | Shares 39,000
Planned buy 30 Aug 2021
Value US$1,674,099.00 | Price 23.92 | Shares 70,000
Planned buy 27 Aug 2021
Value US$858,251.94 | Price 23.17 | Shares 37,038
Planned buy 26 Aug 2021
Value US$906,912.00 | Price 22.67 | Shares 40,000
Planned buy 19 Aug 2021
Value US$1,006,421.05 | Price 21.51 | Shares 46,792
Planned buy 18 Aug 2021
Value US$367,091.99 | Price 21.45 | Shares 17,116
Sale 28 May 2021
Value US$42,792.00 | Price 24.00 | Shares 1,783
Planned sale 28 May 2021
Value US$31,200.00 | Price 24.00 | Shares 1,300
Planned sale 26 May 2021
Value US$307,721.00 | Price 24.23 | Shares 12,700
Sale 6 Apr 2021
Value US$151,163.82 | Price 18.63 | Shares 8,114
Sale 6 Apr 2021
Value US$202,250.44 | Price 18.62 | Shares 10,862
Planned sale 19 Mar 2021
Value US$169,190.00 | Price 24.17 | Shares 7,000
Planned sale 15 Mar 2021
Value US$752,013.00 | Price 25.07 | Shares 30,000
Sale 1 Mar 2021
Value US$34,118.15 | Price 22.55 | Shares 1,513
Planned sale 16 Feb 2021
Value US$16,050.00 | Price 21.40 | Shares 750
Planned sale 28 Jan 2021
Value US$7,200.00 | Price 24.00 | Shares 300
Planned sale 15 Jan 2021
Value US$16,125.00 | Price 21.50 | Shares 750
Planned sale 28 Dec 2020
Value US$354,000.00 | Price 30.00 | Shares 11,800
Planned sale 18 Dec 2020
Value US$52,000.00 | Price 26.00 | Shares 2,000
Planned sale 18 Dec 2020
Value US$7,871.01 | Price 26.24 | Shares 300
Planned sale 18 Dec 2020
Value US$246,183.09 | Price 25.38 | Shares 9,700
Planned sale 15 Dec 2020
Value US$83,837.26 | Price 24.18 | Shares 3,467
Planned sale 15 Dec 2020
Value US$83,589.01 | Price 23.66 | Shares 3,533
Planned sale 15 Dec 2020
Value US$16,382.50 | Price 24.45 | Shares 670
Planned sale 15 Dec 2020
Value US$8,980.20 | Price 23.63 | Shares 380
Planned sale 10 Dec 2020
Value US$260,362.00 | Price 26.04 | Shares 10,000
Planned sale 10 Dec 2020
Value US$488,783.00 | Price 25.20 | Shares 19,400
Planned sale 9 Dec 2020
Value US$15,049.02 | Price 25.08 | Shares 600
Planned sale 30 Nov 2020
Value US$36,000.00 | Price 24.00 | Shares 1,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-10 2023-03-10 B Purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
47,866 -45.6%
17.25
US$1,269,024 		47,866 -45.6% 17.25 US$1,269,024
2023-01-20 2023-01-18 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
7,275 -39.8%
418.47
US$3,234,658 		7,275 -39.8% 418.47 US$3,234,658
2023-01-20 2023-01-18 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
87,492 -2.9%
479.54
US$3,028,788 		87,492 -2.9% 479.54 US$3,028,788
2023-01-20 2023-01-18 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
1,272 -0.4%
26.89
US$34,204 		1,272 -0.4% 26.89 US$34,204
2023-01-20 2023-01-18 S Sale
Marek David C

Principal Executive Officer

Executive Director
8,037 -1.9%
26.89
US$216,115 		8,037 -1.9% 26.89 US$216,115
2023-01-05 2023-01-04 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
2,251 -0.9%
26.90
US$60,552 		2,251 -0.9% 26.90 US$60,552
2023-01-05 2023-01-04 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
2,779 -0.8%
26.90
US$74,755 		2,779 -0.8% 26.90 US$74,755
2022-12-20 2022-12-16 S Sale
Mehra Uneek

Principal Financial Officer

Officer
2,241 -1.1%
26.75
US$59,947 		2,241 -1.1% 26.75 US$59,947
2022-10-20 2022-10-18 S Sale
Marek David C

Principal Executive Officer

Executive Director
11,156 -2.6%
25.20
US$281,131 		11,156 -2.6% 25.20 US$281,131
2022-10-20 2022-10-18 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,604 -0.6%
25.20
US$40,421 		1,604 -0.6% 25.20 US$40,421
2022-10-20 2022-10-18 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
1,703 -1.0%
25.20
US$42,916 		1,703 -1.0% 25.20 US$42,916
2022-10-20 2022-10-18 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
1,933 -0.5%
25.20
US$48,712 		1,933 -0.5% 25.20 US$48,712
2022-10-06 2022-10-04 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
3,679 -1.0%
24.40
US$89,768 		3,679 -1.0% 24.40 US$89,768
2022-10-06 2022-10-04 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
2,738 -1.1%
24.40
US$66,807 		2,738 -1.1% 24.40 US$66,807
2022-09-20 2022-09-16 S Sale
Mehra Uneek

Principal Financial Officer

Officer
9,243 -4.3%
18.86
US$174,323 		9,243 -4.3% 18.86 US$174,323
2022-08-16 2022-08-15 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
31,214 -7.9%
18.23
US$569,031 		31,214 -7.9% 18.23 US$569,031
2022-07-20 2022-07-18 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,606 -0.6%
12.87
US$20,669 		1,606 -0.6% 12.87 US$20,669
2022-07-20 2022-07-18 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
1,935 -0.7%
12.87
US$24,903 		1,935 -0.7% 12.87 US$24,903
2022-07-20 2022-07-18 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
1,704 -1.0%
12.87
US$21,930 		1,704 -1.0% 12.87 US$21,930
2022-07-20 2022-07-18 S Sale
Marek David C

Principal Executive Officer

Executive Director
11,164 -2.5%
12.87
US$143,681 		11,164 -2.5% 12.87 US$143,681
2022-07-08 2022-07-06 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
2,755 -1.1%
13.40
US$36,917 		2,755 -1.1% 13.40 US$36,917
2022-07-08 2022-07-06 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
3,702 -1.3%
13.40
US$49,607 		3,702 -1.3% 13.40 US$49,607
2022-06-01 2022-05-27 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,382 -0.5%
10.07
US$13,917 		1,382 -0.5% 10.07 US$13,917
2022-04-21 2022-04-19 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
4,632 -1.7%
10.45
US$48,404 		4,632 -1.7% 10.45 US$48,404
2022-04-21 2022-04-19 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
7,049 -3.9%
10.45
US$73,662 		7,049 -3.9% 10.45 US$73,662
2022-04-21 2022-04-19 S Sale
Marek David C

Principal Executive Officer

Executive Director
24,594 -5.2%
10.45
US$257,007 		24,594 -5.2% 10.45 US$257,007
2022-04-21 2022-04-19 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
8,002 -2.8%
10.45
US$83,621 		8,002 -2.8% 10.45 US$83,621
2022-04-07 2022-04-05 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,922 -1.2%
13.78
US$26,485 		1,922 -1.2% 13.78 US$26,485
2022-04-07 2022-04-05 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
2,436 -1.4%
13.78
US$33,568 		2,436 -1.4% 13.78 US$33,568
2022-03-03 2022-03-01 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,362 -0.8%
13.35
US$18,183 		1,362 -0.8% 13.35 US$18,183
2022-01-21 2022-01-19 S Sale
Marek David C

Principal Executive Officer

Executive Director
19,882 -5.6%
14.68
US$291,868 		19,882 -5.6% 14.68 US$291,868
2022-01-06 2022-01-04 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
2,271 -1.4%
16.27
US$36,949 		2,271 -1.4% 16.27 US$36,949
2022-01-06 2022-01-04 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
4,475 -2.5%
16.27
US$72,808 		4,475 -2.5% 16.27 US$72,808
2021-12-01 2021-11-29 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,978 -1.2%
19.30
US$38,175 		1,978 -1.2% 19.30 US$38,175
2021-11-05 2021-11-04 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
3,100 -1.8%
24.02
US$74,462 		3,100 -1.8% 24.02 US$74,462
2021-11-05 2021-11-03 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
700 -0.4%
24.00
US$16,800 		700 -0.4% 24.00 US$16,800
2021-10-07 2021-10-05 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
2,738 -1.6%
21.62
US$59,196 		2,738 -1.6% 21.62 US$59,196
2021-10-07 2021-10-05 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
6,671 -3.6%
21.62
US$144,227 		6,671 -3.6% 21.62 US$144,227
2021-09-29 2021-09-27 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
7,000 -3.9%
24.32
US$170,240 		7,000 -3.9% 24.32 US$170,240
2021-09-28 2021-09-27 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
2,232 +0.0%
24.86
US$55,486 		2,232 +0.0% 24.86 US$55,486
2021-09-28 2021-09-27 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
45,768 +0.1%
24.19
US$1,106,904 		45,768 +0.1% 24.19 US$1,106,904
2021-09-28 2021-09-24 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
36,000 +0.1%
23.40
US$842,548 		36,000 +0.1% 23.40 US$842,548
2021-09-14 2021-09-13 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
30,028 +0.1%
23.91
US$717,990 		30,028 +0.1% 23.91 US$717,990
2021-09-14 2021-09-13 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
53,150 +0.1%
23.09
US$1,227,058 		53,150 +0.1% 23.09 US$1,227,058
2021-09-14 2021-09-10 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
30,000 +0.1%
25.11
US$753,390 		30,000 +0.1% 25.11 US$753,390
2021-09-13 2021-09-09 PlS Planned sale
3.2
Curran Terrie
Non-Executive Director
4,850 -100.0%
25.58
US$124,063 		4,850 -100.0% 25.58 US$124,063
2021-09-01 2021-08-31 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
39,000 +0.1%
24.28
US$946,885 		39,000 +0.1% 24.28 US$946,885
2021-09-01 2021-08-30 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
70,000 +0.1%
23.92
US$1,674,099 		70,000 +0.1% 23.92 US$1,674,099
2021-08-30 2021-08-27 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
37,038 +0.1%
23.17
US$858,252 		37,038 +0.1% 23.17 US$858,252
2021-08-30 2021-08-26 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
40,000 +0.1%
22.67
US$906,912 		40,000 +0.1% 22.67 US$906,912
2021-08-20 2021-08-19 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
46,792 +0.1%
21.51
US$1,006,421 		46,792 +0.1% 21.51 US$1,006,421
2021-08-20 2021-08-18 PP Planned purchase
Sumitomo Chemical Co., Ltd.
Large shareholder
17,116 +0.0%
21.45
US$367,092 		17,116 +0.0% 21.45 US$367,092
2021-06-02 2021-05-28 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,783 -1.0%
24.00
US$42,792 		1,783 -1.0% 24.00 US$42,792
2021-06-02 2021-05-28 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,300 -0.7%
24.00
US$31,200 		1,300 -0.7% 24.00 US$31,200
2021-05-28 2021-05-26 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
12,700 -6.7%
24.23
US$307,721 		12,700 -6.7% 24.23 US$307,721
2021-04-08 2021-04-06 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
8,114 -6.0%
18.63
US$151,164 		8,114 -6.0% 18.63 US$151,164
2021-04-08 2021-04-06 S Sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
10,862 -7.4%
18.62
US$202,250 		10,862 -7.4% 18.62 US$202,250
2021-03-23 2021-03-19 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
7,000 -4.9%
24.17
US$169,190 		7,000 -4.9% 24.17 US$169,190
2021-03-17 2021-03-15 PlS Planned sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
30,000 -17.1%
25.07
US$752,013 		30,000 -17.1% 25.07 US$752,013
2021-03-03 2021-03-01 S Sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
1,513 -1.1%
22.55
US$34,118 		1,513 -1.1% 22.55 US$34,118
2021-02-18 2021-02-16 PlS Planned sale
1.2
KARBE FRANK

Principal Fin'l & Accounting

Officer
750 -0.5%
21.40
US$16,050 		750 -0.5% 21.40 US$16,050
2021-02-01 2021-01-28 PlS Planned sale
1.2
KARBE FRANK

Principal Fin'l & Accounting

Officer
300 -0.2%
24.00
US$7,200 		300 -0.2% 24.00 US$7,200
2021-01-20 2021-01-15 PlS Planned sale
1.2
KARBE FRANK

Principal Fin'l & Accounting

Officer
750 -0.5%
21.50
US$16,125 		750 -0.5% 21.50 US$16,125
2020-12-30 2020-12-28 PlS Planned sale
1.2
KARBE FRANK

Principal Fin'l & Accounting

Officer
11,800 -6.7%
30.00
US$354,000 		11,800 -6.7% 30.00 US$354,000
2020-12-22 2020-12-18 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
2,000 -1.4%
26.00
US$52,000 		2,000 -1.4% 26.00 US$52,000
2020-12-22 2020-12-18 PlS Planned sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
300 -0.2%
26.24
US$7,871 		300 -0.2% 26.24 US$7,871
2020-12-22 2020-12-18 PlS Planned sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
9,700 -6.2%
25.38
US$246,183 		9,700 -6.2% 25.38 US$246,183
2020-12-17 2020-12-15 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
3,467 -2.5%
24.18
US$83,837 		3,467 -2.5% 24.18 US$83,837
2020-12-17 2020-12-15 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
3,533 -2.5%
23.66
US$83,589 		3,533 -2.5% 23.66 US$83,589
2020-12-17 2020-12-15 PlS Planned sale
1.2
KARBE FRANK

Principal Fin'l & Accounting

Officer
670 -0.4%
24.45
US$16,383 		670 -0.4% 24.45 US$16,383
2020-12-17 2020-12-15 PlS Planned sale
1.2
KARBE FRANK

Principal Fin'l & Accounting

Officer
380 -0.2%
23.63
US$8,980 		380 -0.2% 23.63 US$8,980
2020-12-14 2020-12-10 PlS Planned sale
Arjona Ferreira Juan Camilo

Chief Medical Officer

Officer
10,000 -6.8%
26.04
US$260,362 		10,000 -6.8% 26.04 US$260,362
2020-12-11 2020-12-10 PlS Planned sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
19,400 -11.7%
25.20
US$488,783 		19,400 -11.7% 25.20 US$488,783
2020-12-11 2020-12-09 PlS Planned sale
Lang Matthew

General Counsel & Corp. Secy.

Officer
600 -0.4%
25.08
US$15,049 		600 -0.4% 25.08 US$15,049
2020-12-02 2020-11-30 PlS Planned sale
1.2
KARBE FRANK

Principal Fin'l & Accounting

Officer
1,500 -0.9%
24.00
US$36,000 		1,500 -0.9% 24.00 US$36,000
Explore more

More insider trading research around Myovant Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America